References
1. Fitzpatrick TB. The validity and practicality of sun-reactive skintypes I through IV. Arch Derm. 1998;124:869-871.
2. Moseley H, Davidson M, Ferguson J. A hazard of artificial tanningunits. Photodermatol Photoimmunol Photomed. 1998;14:79-87.
3. Cool Nurse.com [homepage on the Internet]. Sun Tanning - ButFirst...Some Sun History. [updated 2005; cited 2005 Mar 29].Available from http:// www.coolnurse.com/tanning.htm.
4. Robinson JK, Rigel DS, Amonette RA. Trends in sun exposureknowledge, attitudes, and behaviors: 1986 to 1996.J Am Acad Dermatol.1997;37:179-86.
5. Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, et al.Daily sunscreen application and betacarotene supplementation inprevention of basal-cell and squamous-cell carcinomas of the skin:a randomised controlled trial. Lancet. 1999;354:723-29.
6. Gallagher RP, Rivers JK, Lee TK, Bajdik CD, McLean DI, Coldman AJ.Broad-spectrum sunscreen use and the development of new neviin white children: a randomized controlled trial. J Am Med Assoc.2000;283:2955-60.
7. Nole G, Johnson AW. An analysis of cumulative lifetime solarultraviolet radiation exposure and the benefits of daily sunprotection. Dermatologic Therapy. 2004;17:57-62.
8. Gasparro FP, Mitchnick M, Nash JF. A review of sunscreen safetyand efficacy. Photochemistry and Photobiology. 1998;68(3):243-56.
9. Gilchrest BA. A review of skin ageing and its medical therapy.British J Dermatol. 1996;135:867-875.
10. Philips TJ, Bhawan J, Yaar M, Bello Y, Piccolo D, Nash JF.Effect of daily versus intermittent sunscreen application on solarsimulated UV radiation-induced skin response in humans.J Am Acad Dermatol. 2000;43(4):610-18.
11. Fitzpatrick TB. The validity and practicality of sun-reactive skintypes I through IV. Arch Derm. 1998;124:869-871.
12. WHO.int [homepage on the Internet]. Geneva: World Health Organization;c2005 [cited 2005 Mar 29]. How common is skin cancer?Available from www.who.int/uv/faq/skincancer/en/index1.html.
13. Diffey BL, Tanner PR, Matts PJ, Nash JF. In vitro assessment of thebroad-spectrum ultraviolet protection of sunscreen products.J Am Acad Dermatol. 2000;43(6):1024-35.
14. Procter & Gamble Beauty. Data on file.
15. United States Food and Drug Administration. Sunscreen DrugProducts for Over-the-counter Human Use; Final Monograph.Federal Register. 1999;64(98):27666-693.
16. United States Food and Drug Administration. Sunscreen DrugProducts for Over-the-counter Human Use; Final Monograph.Federal Register. 1999;64(98):27666-693.
17. Nash JF, Javaid Z, Tanner P, Rigel D. Impact of sunscreens onVitamin D: A risk/benefit analysis. J Am Acad Dermatol.2005;52(3):161.
18. Procter & Gamble Beauty. Data on file.
19. Procter & Gamble Beauty. Data on file.
20. Philips TJ, Bhawan J, Yaar M, Bello Y, Piccolo D, Nash JF.Effect of daily versus intermittent sunscreen application on solarsimulated UV radiation-induced skin response in humans.J Am Acad Dermatol. 2000;43(4):610-18.
21. Hillebrand G. Quantitative evaluation of skin condition in anepidemiological survey of females living in northern versussouthern Japan. J Dermatol Sci. 2001;(27 Suppl 1):S42-52.
22. Grosick TL, Tanner PR. Efficacy as used, not as tested, is truemeasure of sunscreen performance. Proceedings of the 62ndAmerican Academy of Dermatology Annual Meeting;2004 6-11 Feb.; Washington, DC, USA.
23. Grosick TL, Tanner PR. Efficacy as used, not as tested, is truemeasure of sunscreen performance. Proceedings of the 62ndAmerican Academy of Dermatology Annual Meeting;2004 6-11 Feb.; Washington, DC, USA.
24. United States Food and Drug Administration. Sunscreen DrugProducts for Over-the-counter Human Use; Final Monograph.Federal Register. 1999;64(98):27666-693.
25. Grosick TL, Tanner PR. Efficacy as used, not as tested, is truemeasure of sunscreen performance. Proceedings of the 62ndAmerican Academy of Dermatology Annual Meeting;2004 6-11 Feb.; Washington, DC, USA.
26. Nash JF, Tanner PR, Grosick TL, Zimnawoda M, Ryan M.Sunscreen market analysis: The evolution and use of UVA-1 actives.Proceedings of the 62nd American Academy of DermatologyAnnual Meeting; 2004 6-11 Feb.; Washington, DC, USA.
27. Diffey BL, Tanner PR, Matts PJ, Nash JF. In vitro assessment of thebroad-spectrum ultraviolet protection of sunscreen products.J Am Acad Dermatol. 2000;43(6):1024-35.